SECAUCUS, N.J., Oct. 23, 2018 /PRNewswire/ -- Quest
Diagnostics (NYSE: DGX), the world's leading provider of
diagnostic information services, will host an Investor Day for
institutional investors and financial analysts in New York
City on Thursday, November 29, 2018 at The
InterContinental New York Times Square Hotel at 300 W. 44th
St.
During the event, Steve Rusckowski, Chairman, President and
Chief Executive Officer, Mark
Guinan, Executive Vice President & Chief Financial
Officer, and other senior executives will provide updated views of
the U.S. laboratory market and the company's 2-point strategy,
including key growth opportunities as well as initiatives to drive
operational excellence.
Advance registration is required for those planning to attend in
person. To register for the event, please go to the following
website: register.questdiagnostics.com. A live webcast of the
event will be broadcast on the Investor Relations page of
the Quest Diagnostics website. Additional information on
accessing the webcast will be provided at a future date.
About Quest Diagnostics
Quest
Diagnostics empowers people to take action to improve health
outcomes. Derived from the world's largest database of
clinical lab results, our diagnostic insights reveal new avenues to
identify and treat disease, inspire healthy behaviors and improve
health care management. Quest annually serves one in three adult
Americans and half the physicians and hospitals
in the United States, and our 45,000 employees understand
that, in the right hands and with the right context, our diagnostic
insights can inspire actions that transform
lives. www.QuestDiagnostics.com.
Quest, Quest Diagnostics, and all associated Quest Diagnostics
registered or unregistered trademarks are the property of Quest
Diagnostics. All third-party marks are the property of their
respective owners.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/quest-diagnostics-to-host-investor-day-on-november-29-2018-300736224.html
SOURCE Quest Diagnostics